Jan. 7 at 11:34 AM
Truist y'day⬆️Favorite Pick
$IDYA's PT to
$60 from
$59, reiterated at Buy and said: Daro 1L MUM PFS Topline in 1Q26 - Favorable Reward-Risk Supports Potential 2H26E Launch & Our 1x1 Tidbits
$IMCR $REPL $BMY $PFE MRK
Truist added: IDYA, one of our favorite picks for 2026 is approaching the most important near-term catalyst with daro's topline PFS readout in 1L MUM (1Q26).
Based on strong ph.Il data and supportive KOL feedback, we view the setup as attractive with favorable reward-risk profile and assign 85% PoS for our Good/Best Case scenarios - potential for 15-25% upside.
In our 1x1, mgmt reiterated that a positive PFS outcome could support accelerated approval consideration, potentially by 2H26E (our est.), further de-risking our projected peak ~
$1.7B revenue for daro.
On the de-risked setup into the ph.II/III PFS readout, we reiterate our Buy rating and increase our PT to
$60 PT (from
$59).
